Premaitha Health PLC (LON:NIPT) insider Barry Kenneth Hextall bought 100,000 shares of Premaitha Health stock in a transaction that occurred on Thursday, October 4th. The shares were acquired at an average price of GBX 10 ($0.13) per share, with a total value of £10,000 ($13,025.92).
Shares of NIPT opened at GBX 9.85 ($0.13) on Monday. Premaitha Health PLC has a 12 month low of GBX 4.05 ($0.05) and a 12 month high of GBX 12.50 ($0.16).
Separately, FinnCap restated a “corporate” rating on shares of Premaitha Health in a report on Wednesday, September 19th.
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome.
See Also: What is a Fiduciary?
Receive News & Ratings for Premaitha Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Premaitha Health and related companies with MarketBeat.com's FREE daily email newsletter.